Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipid Storage Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03519646
What this trial is testing

Eliglustat on Gaucher Disease Type IIIB

Who this might be right for
Gaucher Disease, Type III
National Taiwan University Hospital 4
Testing effectiveness (Phase 2)Study completedNCT01685216
What this trial is testing

Efficacy and Safety Study of Velaglucerase Alfa in Children and Adolescents With Type 3 Gaucher Disease

Who this might be right for
Gaucher Disease, Type 3
Shire 7
Testing effectiveness (Phase 2)Study completedNCT00433147
What this trial is testing

AT2101 (Afegostat Tartrate) in Adult Patients With Type 1 Gaucher Disease Currently Receiving Enzyme Replacement Therapy

Who this might be right for
Gaucher Disease, Type 1Type 1 Gaucher DiseaseGaucher Disease
Amicus Therapeutics 30
Not applicableStudy completedNCT01325025
What this trial is testing

Imaging Study of the White Matter Lesions in Children With Metachromatic Leucodystrophy

Who this might be right for
Late Infantile Metachromatic Leukodystrophy
Assistance Publique - Hôpitaux de Paris 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT02843035
What this trial is testing

Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 With Venglustat Monotherapy Extension

Who this might be right for
Gaucher Disease Type 1Gaucher Disease Type 3
Genzyme, a Sanofi Company 12
Large-scale testing (Phase 3)Study completedNCT02770625
What this trial is testing

Phase III Study of ISU302 in Patients With Type 1 Gaucher Disease

Who this might be right for
Gaucher Disease, Type 1
ISU Abxis Co., Ltd. 8
Large-scale testing (Phase 3)Study completedNCT00176904
What this trial is testing

Stem Cell Transplant for Inborn Errors of Metabolism

Who this might be right for
AdrenoleukodystrophyMetachromatic LeukodystrophyGloboid Cell Leukodystrophy+8 more
Masonic Cancer Center, University of Minnesota 135
Not applicableStudy completedNCT00728364
What this trial is testing

Anderson-Fabry Disease in Chronic Kidney Disease Patients Not on Renal Replacement Therapy

Who this might be right for
Focus of Study: Prevalence of Fabry Disease in CKD Population
Klinikum Wels-Grieskirchen 4,353
Post-approval studies (Phase 4)Study completedNCT03910621
What this trial is testing

Safety and Efficacy of Miglustat in Chinese NPC Patients

Who this might be right for
Niemann-Pick Disease, Type C
Actelion 17
Large-scale testing (Phase 3)Ended earlyNCT04840667
What this trial is testing

Replagal in Treatment-naïve Adults With Fabry Disease

Who this might be right for
Fabry Disease
Shire 17
Not applicableStudy completedNCT02985710
What this trial is testing

Assessment of Small Fiber Neuropathy in Rare Diseases Using Sudoscan

Who this might be right for
Small Fiber NeuropathyFabry DiseaseEhlers Danlos Syndrome+1 more
Massachusetts General Hospital 102
Post-approval studies (Phase 4)UnknownNCT03721627
What this trial is testing

Chronic Hepatitis C Treatment in Egyptian Children With Gaucher Disease.

Who this might be right for
Gaucher DiseaseHCV
Mansoura University Children Hospital 10
Not applicableUnknownNCT06539169
What this trial is testing

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

Who this might be right for
Alpha-ThalassemiaBeta-ThalassemiaAmyloidosis+14 more
xCures 1,000
Large-scale testing (Phase 3)Study completedNCT00553631
What this trial is testing

Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) ERT Compared With Imiglucerase in Type I Gaucher Disease

Who this might be right for
Gaucher Disease, Type 1
Shire 34
Not applicableStudy completedNCT00302146
What this trial is testing

Positron Emission Tomography (PET) Imaging in People With Gaucher Mutations

Who this might be right for
Parkinson DiseaseGaucher Disease
National Human Genome Research Institute (NHGRI) 64
Post-approval studies (Phase 4)Study completedNCT01650779
What this trial is testing

A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta

Who this might be right for
Fabry Disease
Genzyme, a Sanofi Company 15
Not applicableUnknownNCT01590095
What this trial is testing

WASH Benefits Bangladesh

Who this might be right for
MalnutritionDiarrheaChild Development
International Centre for Diarrhoeal Disease Research, Bangladesh 5,040
Not applicableStudy completedNCT03289065
What this trial is testing

Fabry Outcome Survey (FOS)

Who this might be right for
Fabry Disease
Shire 4,000
Not applicableLooking for participantsNCT00029965
What this trial is testing

Natural History of Glycosphingolipid Storage Disorders and Glycoprotein Disorders

Who this might be right for
Neurological RegressionMyoclonusCherry Red Spot+1 more
National Human Genome Research Institute (NHGRI) 200
Large-scale testing (Phase 3)Ended earlyNCT04221451
What this trial is testing

A Multinational, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, and Safety of Venglustat in Late-onset GM2

Who this might be right for
Tay-Sachs DiseaseSandhoff Disease
Genzyme, a Sanofi Company 75
Next Page